BD has introduced the ability to execute in vitro rapid identification (ID) and antimicrobial susceptibility testing (AST) for meropenem-vaborbactam in its latest panel for the BD Phoenix Automated Microbiology System, which detects resistance in Enterobacteriaceae, Non-Enterobacteriaceae and most gram-positive bacteria isolates from pure culture belonging to the genera Staphylococcus, Enterococcus and Streptococcus.
The BD Phoenix offers clinical microbiology laboratories the ability to rapidly test antimicrobial resistances or susceptibilities. The company’s rapid results for ID and AST are powered through an oxidation-reduction indicator with turbidity measurement for growth detection, as well as full on-panel antimicrobial concentrations and the BDXpert system for data analysis.
Phone: 02 8875 7000
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
